The global fertility services industry is poised for significant expansion, projected to grow at a compound annual growth rate (CAGR) of 7% over the next decade. This growth is driven by factors such as an aging global population, increasing infertility rates, and couples postponing childbirth. The demand for fertility services is particularly strong in Asia, where the market is still developing compared to the more mature sectors in the West. The Asia Pacific region is forecasted to experience a remarkable CAGR of 10% over the next ten years, outstripping the global average.
As the market matures, regional players are beginning to emerge, aiming to consolidate the fragmented landscape. These players are leveraging economies of scale, differing regulatory environments, and sharing best practices, expertise, and technology to enhance patient outcomes and success rates.
The fertility services sector is attracting substantial interest from both strategic and financial investors, drawn by its compelling business model. The sector benefits from high entry barriers—such as licensing requirements, brand reputation, talent acquisition, and clinical expertise—as well as robust EBITDA margins and lower capital intensity compared to hospitals.
Southeast Asia (SEA) is particularly appealing to global investors due to its fragmented market and underserved populations with rising local demand for fertility services. India is also a focal point, with the IVF sector projected to grow at a CAGR of 16% over the next decade. Scaled players in India are gaining momentum with support from financial backers.
Over the next five years, substantial mergers and acquisitions (M&A) activity is anticipated in the fertility services sector across Asia, with a surge in SEA and India as major players aim to secure their positions in the region.
Related Links:
